Functional and total IGFBP3 for the assessment of disorders of the GH/IGF1 axis in children with chronic kidney disease, GH deficiency, or short stature after SGA status at birth

European Journal of Endocrinology

Volumn 166, Issue 5, 2012, Pages 923-931

  Buscher A K ^a   Buscher R ^a   Pridzun, L ^c   Langkamp, M ^c   Wachendorfer, N ^c   Hoyer, P F ^a   Ranke, M B ^b   Hauffa, B P ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Mediagnost Corporation   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RENAL REPLACEMENT THERAPY; SCHOOL CHILD; SHORT STATURE; SMALL FOR DATE INFANT; UREMIA;

ADOLESCENT; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DWARFISM, PITUITARY; FEMALE; GESTATIONAL AGE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84862082164     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0923     Document Type: Article

References (32)

1. Seikaly MG, Ho PL, Emmett L, Fine RN & Tejani A. Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. Pediatric Nephrology 2003 18 796-804. (doi:10.1007/s00467-003-1158-5)
2. Seikaly MG, Salhab N, Gipson D, Yiu V & Stablein D. Stature in children with chronic kidney disease: analysis of NAPRTCS database. Pediatric Nephrology 2006 21 793-799. (doi:10.1007/s00467-006-0040-7)
3. Mehls O, Wuhl E, Tönshoff B, Schaefer F, Nissel R & Haffner D. Growth hormone treatment in short children with chronic kidney disease. Acta Paediatrica 2008 97 1159-1164. (doi:10.1111/j.1651-2227.2008.00845.x)
4. Roelfsema V & Clark RG. The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure. Journal of the American Society of Nephrology 2001 12 1297-1306. (Pubitemid 32472645)
5. Seikaly MG, Salhab N, Warady BA & Stablein D. Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS. Pediatric Nephrology 2007 22 1195-1204. (doi:10.1007/s00467-007-0497-z)
6. Seikaly MG, Waber P, Warady BA & Stablein D. The effect of rhGH on height velocity and BMI in children with CKD: a report of the NAPRTCS registry. Pediatric Nephrology 2009 24 1711-1717. (doi:10.1007/s00467-009-1183-0)
7. Nissel R, Brazda I, Feneberg R, Wigger M, Greiner C, Querfeld U & Haffner D. Effect of renal transplantation in childhood on longitudinal growth and adult height. Kidney International 2004 66 792-800. (doi:10.1111/j.1523- 1755.2004.00805.x)
8. Frystyk J, Ivarsen P, Skjærbæk C, Flyvbjerg A, Pedersen EB & Orskov H. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney International 1999 56 2076-2084. (doi:10.1046/j.1523-1755.1999.00798.x)
9. Baxter RC. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. American Journal of Physiology. Endocrinology and Metabolism 2000 278 E967-E976. (Pubitemid 30439132)
10. Mohan S & Baylink DJ. IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. Journal of Endocrinology 2002 175 19-31. (doi:10.1677/joe.0.1750019)
11. Juul A, Flyvbjerg A, Frystyk J, Müller J & Skakkebaek NE. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty. Clinical Endocrinology 1996 44 515-523. (doi:10.1046/j.1365- 2265.1996.711531.x)
12. Jones JI & Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 1995 16 3-34. (doi:10.1210/edrv-16-1-3)
13. Lamson G, Giudice LC, Cohen P, Liu F, Gargosky S, Muller HL, Oh Y, Wilson KF, Hintz RL & Rosenfeld RG. Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo. Growth Regulation 1993 3 91-95.
14. Tönshoff B, Kiepe D & Ciarmatori S. Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatric Nephrology 2005 20 279-289. (doi:10.1007/s00467-005-1821-0)
15. Tönshoff B, Blum WF, Wingen AM, Mehls O, Rätsch I, Michelis K, Kapogiannis T, Lennert T, Jung F, Gellert S, Tulassay T, Sallay P, Von Lilien T, Querfeld U, Von Wendt-Gökner MA, Bonzel KE, Gusmano R, Verrina E, Offner G, Fabian-Bach C, Appiani A, Bettinelli A, Feber J & Picca S. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. Journal of Clinical Endocrinology and Metabolism 1995 80 2684-2691. (doi:10.1210/jc.80.9.2684)
16. Houang M, Cabrol S, Perin L, Ducos B, Bensman A & Le Bouc Y. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure. Growth Hormone & IGF Research 2000 10 332-341. (doi:10.1054/ghir.2000.0178)
17. Tönshoff B, Blum WF & Mehls O. Derangements of the somatotropic hormone axis in chronic renal failure. Kidney International. Supplement 1997 58 S106-S113.
18. Blum WF, Ranke MB, Kietzmann K, Tönshoff B & Mehls O. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatric Nephrology 1991 5 539-544. (doi:10.1007/BF01453697)
19. Ding H, Gao XL, Hirschberg R, Vadgama JV & Kopple JD. Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect. Journal of Clinical Investigation 1996 97 1064-1075. (doi:10.1172/JCI118499)
20. Rees L & Kovacs G. Growth and puberty. In ESPN Handbook, pp 383-384. Eds Cochat P. Lyon: Medcom, 2002.
21. Langkamp M, Weber K, Kirschner M, Pridzun L & Ranke MB. Validation of functional insulin-like growth factor binding protein- 3 measurement by a ligand immunoassay. Clinical Laboratory 2010 56 535-542.
22. National Kidney Foundation. Part 4. Definition and classification of stages of chronic kidney disease. Guideline 1. Definition and stages of chronic kidney disease. American Journal of Kidney Diseases 2002 39 S46-S75. (doi:10.1053/ajkd.2002.30943)
23. Blum WF & Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regulation 1994 4 (Suppl 1) 11-19.
24. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Hormone and Metabolic Research 2003 35 694-704. (doi:10.1055/s-2004- 814147)
25. Schwartz GJ, Brion LP & Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatric Clinics of North America 1987 34 571-590. (Pubitemid 17080631)
26. McCusker RH, Busby WH, Dehoff MH, Camacho-Hubner C & Clemmons DR. Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins. Endocrinology 1991 129 939-949. (doi:10.1210/endo-129-2-939)
27. Firth SM & Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocrine Reviews 2002 23 824-854. (doi:10.1210/er. 2001-0033)
28. De Mellow JS & Baxter RC. Growth hormone-dependent insulinlike growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochemical and Biophysical Research Communications 1988 156 199-204. (doi:10.1016/S0006-291X(88)80824-6)
29. Durham SK, Mohan S, Liu F, Baker BK, Lee PD, Hintz RL, Conover CA & Powell DR. Bioactivity of a 29-kilodalton insulinlike growth factor binding protein-3 fragment present in excess in chronic renal failure serum. Pediatric Research 1997 42 335-341. (doi:10.1203/00006450-199709000-00014)
30. Gargosky SE, Hasegawa T, Tapanainen P, MacGillivray M, Hasegawa Y & Rosenfeld RG. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease. Journal of Clinical Endocrinology and Metabolism 1993 76 1631-1637. (doi:10 1210/jc.76.6.1631)
31. Kirsch S,Widart J, Louette J, Focant JF & De Pauw E. Development of an absolute quantification method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry. Journal of Chromatography A 2007 1153 300-306. (doi:10.1016/j.chroma.2007.03.058)
32. Blum WF. Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: evidence for reduced secretion of IGFs. Acta Paediatrica Scandinavica 1991 80 (Suppl 379) 24-31. (doi:10.1111/j.1651-2227.1991.tb12039.x)